Signal active
Organization
Contact Information
Overview
Sonio is an AI-based support platform for fetal ultrasound, helping practitioners analyze and diagnose congenital malformations. Sonio combines the patient’s medical history, genetic and biological data, and ultrasound semiology to assist physicians on the path to the right diagnosis. It assists sonographers during prenatal screening scans, helping them ensure that they have not forgotten anything, take risk factors into account, and facilitate the sharing of images with patients and other health professionals.
About
Artificial Intelligence (AI), Health Care, Medical Device, Health Diagnostics
2020
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Sonio headquartered in Europe, operates in the Artificial Intelligence (AI), Health Care, Medical Device, Health Diagnostics sector. The company focuses on Artificial Intelligence (AI) and has secured $1.9B in funding across 64 round(s). With a team of 11-50 employees, Sonio is actively contributing to advancements in Artificial Intelligence (AI). Their latest funding round, Series A - Sonio, raised $14.3M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
4
7
0
$30.2M
Details
3
Sonio has raised a total of $30.2M in funding over 3 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2022 | Seed | 5.2M | ||
2022 | Seed | 8.0M | ||
2023 | Early Stage Venture | 14.3M |
Investors
Sonio is funded by 20 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Sonio | - | FUNDING ROUND - Sonio | 14.3M |
Elaia | - | FUNDING ROUND - Elaia | 14.3M |
Sonio | - | FUNDING ROUND - Sonio | 14.3M |
La French Tech | - | FUNDING ROUND - La French Tech | 14.3M |
Recent Activity
There is no recent news or activity for this profile.